.png
)
The Ministry of Health and Family Welfare has formally added the widely used nerve-pain drug Pregabalin to Schedule H1 of the Drugs Rules, 1945 — a category reserved for substances with high abuse potential. The Government of India has officially…
Central Drugs Standard Control Organisation (CDSCO) in its latest notification has moved to tighten oversight of the booming cosmetics industry in India, issuing unambiguous guidance on what constitutes a cosmetic product, how it may lawfully be used, and what actions…
The Central Drugs Standard Control Organization (CDSCO), operating under the Directorate General of Health Services, Government of India, has issued a sweeping directive to all State and Union Territory Drug Controllers, calling for urgent and coordinated enforcement action against the…
06th May,2026 The Central Drugs Standard Control Organisation (CDSCO) has announced a new step to clear old and pending applications on the SUGAM portal. Many applications are stuck because applicants did not reply to the queries raised by CDSCO officials.…
05th May, 2026 In a decisive move reinforcing India’s drug regulatory framework, the Delhi High Court has delivered a significant judgment that could reshape how pharmaceutical companies approach approvals—especially for Fixed Dose Combinations (FDCs) and other “new drugs.” The ruling…